Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $7.61B | $7.22B | +5.40% |
Cost of Revenue | $1.91B | $1.73B | +10.53% |
Net Income | $1.34B | $1.37B | -1.74% |
EPS (Basic) | $9.16 | $9.38 | -2.35% |
EPS (Diluted) | $9.14 | $9.35 | -2.25% |
SG&A Expense | $1.75B | $1.72B | +1.59% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $29.21B | $28.31B | +3.16% |
Current Assets | $8.94B | $6.83B | +30.83% |
Total Liabilities | $11B | $11.95B | -7.98% |
Current Liabilities | $3.29B | $5.42B | -39.35% |
Long-Term Debt | $6.29B | $4.55B | +38.26% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $1.69B | $2.11B | -19.95% |
Investing Cash Flow | $-139.4M | $-780.6M | +82.14% |
Financing Cash Flow | $-164.9M | $-691.4M | +76.15% |
D&A | $579.7M | $489.2M | +18.50% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Net Margin | 17.6% | — | — |
ROA | 4.6% | — | — |
Current Ratio | $2.716 | — | — |
Other companies in Biotechnology